Publications by authors named "Serges Billong"
HIV drug resistance following pre-exposure prophylaxis failure among key populations in sub-Saharan Africa: a systematic review and meta-analysis protocol.
Ther Adv Infect Dis
December 2024
Article Synopsis
- Key populations (KP), which are crucial in addressing HIV, represent 70% of new infections globally and are the focus of a study examining drug resistance related to PrEP failure in sub-Saharan Africa.
- The research will systematically review various studies to determine the prevalence of HIV drug resistance (HIVDR) among these populations after PrEP failure, analyzing data from diverse groups including gay men, sex workers, and people who inject drugs.
- Findings aim to identify the rates of PrEP failure and drug resistance, helping improve HIV prevention strategies and inform medical practices for effective antiretroviral use in KP within sub-Saharan Africa.
Introduction: COVID-19 is an infectious and contagious disease declared as public health emergency of international concern in 2020. Given its high morbidity and mortality, one of the responses to this pandemic is vaccination, which has posed a serious problem of acceptance among the population in sub-Saharan Africa (SSA) and Cameroon in particular. Thus, the purpose of this study was to contribute to a better response to the pandemic in Cameroon by measuring the effectiveness of the COVID-19 vaccine.
View Article and Find Full Text PDFBackground: The African continent accounts for over 70% of people infected with Human Immunodeficiency Virus (HIV). The HIV sero-prevalence rate in Africa is estimated at 4.3%.
View Article and Find Full Text PDFBackground: Knowledge of the characteristics of patients co-infected with tuberculosis (TB) and human immunodeficiency virus (HIV) when TB treatment is initiated would allow clinicians to improve care and help policy-makers develop relevant and realistic guidelines. The aim of this study was to describe socio-demographic, clinical, and laboratory characteristics of TB/HIV co-infected patients starting inpatient TB treatment in Yaoundé, Cameroon.
Methods: We conducted a retrospective cross-sectional study, collecting data from medical records of HIV-infected patients with TB, aged 15 years old or more, hospitalized in the Infectious Diseases Unit of the Yaoundé Central Hospital, Cameroon from January 1, 2006 to June 30, 2013.
Background: Contributors to fatal outcomes in TB/HIV co-infected patients actively undergoing TB treatment are poorly characterized. The aim was to assess factors associated with death in TB/HIV co-infected patients during the initial 6 months of TB treatment.
Methods: We conducted a hospital-based retrospective cohort study from January 2006 to December 2013 at the Yaoundé Central Hospital, Cameroon.